secwatch.observer — SEC 8-K summary
======================================

Issuer:     Perspective Therapeutics, Inc. (CATX)
CIK:        0000728387
Form:       8-K
Filed at:   2023-01-30T23:59:59+00:00
Accession:  0001437749-23-002010
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Isoray shareholders approve charter amendment to increase authorized shares; merger with Viewpoint on track
--------------------------------------------------------------------------------

- Shareholders approved amendment to increase authorized common shares to 750,000,000.
- Vote: 71,844,322 for (50.55% of outstanding), 14,571,252 against, 948,682 abstain, 16,492,269 broker non-votes.
- Removal of share cap clears a key condition for the pending merger with Viewpoint Molecular Targeting.
- Merger expected to close in the near future.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/728387/000143774923002010/0001437749-23-002010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/728387/000143774923002010/isr20230127_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-002010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer